| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
53,856,000 |
| Market
Cap: |
924.17(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.17 - $23.89 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Consumer Non-Durables |
| Level
III Sector: |
Packaging & Containers |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cryoport is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Co. operates in two reportable segments: Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment provides a platform of temperature-controlled solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and cold chain logistics capability. The Global Bioservices segment provides a temperature-controlled sample management solution to the life science industry, including specimen storage, sample processing, collection, and retrieval.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
73,940 |
75,740 |
272,395 |
295,816 |
| Total Sell Value |
$1,147,757 |
$1,176,769 |
$5,226,014 |
$5,805,634 |
| Total People Sold |
4 |
5 |
6 |
6 |
| Total Sell Transactions |
10 |
12 |
17 |
26 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zecchini Edward J |
Director |
– • – |
2021-05-13 |
4 |
AS |
$51.23 |
$278,984 |
D/D |
(5,417) |
35,023 |
|
34% |
|
| Zecchini Edward J |
Director |
– • – |
2021-05-13 |
4 |
OE |
$4.80 |
$26,002 |
D/D |
5,417 |
40,440 |
|
- |
|
| Baddour Linda |
Director |
– • – |
2021-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
341 |
341 |
|
- |
|
| Zecchini Edward J |
Director |
– • – |
2021-04-08 |
4 |
AS |
$51.81 |
$282,180 |
D/D |
(5,417) |
0 |
|
2% |
|
| Zecchini Edward J |
Director |
– • – |
2021-04-08 |
4 |
OE |
$4.80 |
$26,002 |
D/D |
5,417 |
5,417 |
|
- |
|
| Berman Richard J |
Director |
– • – |
2021-04-07 |
4 |
OE |
$9.29 |
$363,742 |
D/D |
27,789 |
100,000 |
|
- |
|
| Hancock Daniel M |
Director |
– • – |
2021-03-31 |
4 |
A |
$50.24 |
$11,505 |
D/D |
229 |
4,627 |
|
- |
|
| Berman Richard J |
Director |
– • – |
2021-03-24 |
4 |
OE |
$4.80 |
$383,986 |
D/D |
51,129 |
72,211 |
|
- |
|
| Zecchini Edward J |
Director |
– • – |
2021-03-11 |
4 |
AS |
$55.65 |
$231,887 |
D/D |
(4,167) |
35,023 |
|
2% |
|
| Zecchini Edward J |
Director |
– • – |
2021-03-11 |
4 |
OE |
$5.04 |
$21,002 |
D/D |
4,167 |
39,190 |
|
- |
|
| Sawicki Mark W |
Chief Scientific Officer |
• – – |
2021-03-10 |
4 |
S |
$54.65 |
$734,934 |
D/D |
(13,331) |
36,073 |
|
-5% |
|
| Sawicki Mark W |
Chief Scientific Officer |
• – – |
2021-03-10 |
4 |
OE |
$1.87 |
$86,319 |
D/D |
30,404 |
49,404 |
|
- |
|
| Sawicki Mark W |
Chief Scientific OfficerOffice |
• – – |
2021-02-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,000 |
|
4% |
|
| Berman Richard J |
Director |
– • – |
2021-02-25 |
4 |
OE |
$4.56 |
$100,002 |
D/D |
21,082 |
21,082 |
|
- |
|
| Schwarzman Stephen A |
10% Owner |
– – • |
2021-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,312,860 |
45,338 |
|
- |
|
| Blackstone Tactical Opportunities Associates Iii - |
10% Owner |
– – • |
2021-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,312,860 |
45,338 |
|
- |
|
| Zecchini Edward J |
Director |
– • – |
2020-12-31 |
4 |
A |
$44.11 |
$9,175 |
D/D |
208 |
35,023 |
|
- |
|
| Hancock Daniel M |
Director |
– • – |
2020-12-31 |
4 |
A |
$44.11 |
$11,513 |
D/D |
261 |
4,398 |
|
- |
|
| Shelton Jerrell |
President, CEO |
• • – |
2020-12-28 |
4 |
OE |
$5.00 |
$499,994 |
D/D |
91,560 |
493,156 |
|
- |
|
| Mandalam Ramkumar |
Director |
– • – |
2020-11-24 |
4 |
S |
$48.00 |
$532,416 |
D/D |
(11,092) |
20,054 |
|
-12% |
|
| Berman Richard J |
Director |
– • – |
2020-11-11 |
4 |
S |
$55.55 |
$1,110,934 |
D/D |
(20,000) |
0 |
|
11% |
|
| Berman Richard J |
Director |
– • – |
2020-11-11 |
4 |
OE |
$3.07 |
$78,833 |
D/D |
20,000 |
20,000 |
|
- |
|
| Schwarzman Stephen A |
10% Owner |
– – • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
675,536 |
|
61% |
|
| Blackstone Tactical Opportunities Associates Iii - |
10% Owner |
– – • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
675,536 |
|
61% |
|
| Hancock Daniel M |
Director |
– • – |
2020-09-30 |
4 |
A |
$47.82 |
$11,477 |
D/D |
240 |
4,137 |
|
- |
|
263 Records found
|
|
Page 6 of 11 |
|
|
0.35 (2.08%) 
